GleamWall
中文EN

AGL agilon health, inc.

Services-Misc Health & Allied Services, NEC · NYSE · SEC CIK 1831097 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY2.0%
TTM net income YoY71.7%
TTM EPS YoY73.5%
Revenue 3-yr CAGR15.0%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin-2.6%
Net margin-1.5%
FCF margin-0.3%
EBITDA margin-2.1%

Returns

ROE-29.7%
ROA-5.5%
ROIC (approx.)-79.4%
Asset turnover3.80x

Leverage & solvency

Liabilities / assets82.1%
Debt / equity0.11x
Current ratio1.13x
Interest coverage-22.38x

Cash quality & payout

Operating cash flow / net income0.05x
Accruals ratio-5.2%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue$5.93B$6.06B
SG&A expense$238.54M$268.91M
Operating income-$463.24M-$292.13M
Interest expense$6.64M$6.18M
Pretax income-$404.10M-$248.83M
Income tax$1.25M$1.45M
Net income-$391.35M-$260.15M
EBITDA-$434.64M-$267.67M
EPS (diluted)——
Weighted avg. shares (diluted)413.97M410.97M
Balance sheet
Cash & equivalents$173.71M$188.23M
Receivables$673.79M$1.02B
Current assets$1.10B$1.46B
PP&E, net$25.42M$28.17M
Goodwill$0$24.13M
Intangibles$65.72M$72.77M
Total assets$1.27B$1.73B
Current liabilities$1.08B$1.15B
Short-term debt$19.24M$0
Long-term debt$15.75M$34.90M
Total debt$34.99M$34.90M
Total liabilities$1.14B$1.26B
Shareholders' equity$126.73M$470.95M
Net debt-$138.72M-$153.33M
Shares outstanding16.59M412.19M
Cash flow statement
Operating cash flow-$105.76M-$57.78M
Capital expenditure$13.24M$13.25M
Free cash flow-$119.00M-$71.03M
Investing cash flow$88.61M$139.89M
Financing cash flow-$2.99M-$2.58M
Depreciation & amortization$28.59M$24.46M
Stock-based compensation$49.12M$50.66M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company does not report gross profit in XBRL.

· This company reports EPS only by share class (e.g. class A/B), so it is shown as —.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.